Skip to content

A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients with Ulcerative Colitis

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510324-77-00
Acronym
SOR102-101
Enrollment
9
Registered
2024-06-14
Start date
2024-10-20
Completion date
2024-10-21
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Sponsors

Sorriso Pharmaceuticals Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Bulgaria, Poland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026